Target intelligence / Profile preview

Dengue Virus Envelope Protein (E protein)

Target
E protein
Molecular classification
Glycoprotein, Viral protein
01

Overview

The dengue virus envelope (E) protein is a membrane-spanning glycoprotein that plays a central role in the viral life cycle. It is the principal determinant of virion assembly and acts as the fusion catalyst for merging viral and host cell membranes. The E protein mediates viral attachment to host cells, entry via membrane fusion, and is also the primary target for neutralizing antibodies. On mature virions, E proteins are arranged as antiparallel homodimers on the surface, forming a herringbone pattern within lipid rafts. Upon exposure to low pH during endocytosis, these dimers rearrange into trimers to drive membrane fusion. Glycosylation sites on E are critical for interaction with cell-surface lectins such as DC-SIGN; both N-linked glycosylation sites at Asn-67 (unique to dengue) and Asn-153 (conserved among flaviviruses) are required for efficient recognition by DC-SIGN-expressing dendritic cells. A hydrophobic pocket within domain II influences pH threshold for triggering fusion; this site can accept small ligands or inhibitors that may block conformational changes necessary for entry—a potential antiviral drug target.

Other names
DENV E proteinDengue virus envelope glycoprotein
02

Mechanism of action

Inhibition of viral entry by blocking conformational changes required for membrane fusion; antibody-mediated neutralization of the virus.

03

Biological functions

Viral entryReceptor bindingMembrane fusionAntigen presentationVirion assembly
04

Disease associations

InfectionDengue feverDengue hemorrhagic feverDengue shock syndrome
05

Safety considerations

Antibody-dependent enhancement (ADE)
06

Interacting drugs

Small molecule inhibitors targeting the domain II hydrophobic pocket

1 more in the full profile.

Beyond the preview

Go deeper on Dengue Virus Envelope Protein (E protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dengue Virus Envelope Protein (E protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call